Item 7.01 Regulation FD Disclosure.

As previously announced, Precision BioSciences, Inc. (the "Company") will be presenting at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 15, 2020. A link to the live webcast is available here, and a copy of the presentation materials to be discussed will be available on the Investors & Media page of the Company's website at https://investor.precisionbiosciences.com. Following the conference, a replay of the webcast will be archived for 30 days on the Investors & Media page of the Company's website.

The information in this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses